by Our Special Correspondent in Moscow
Lieutenant General Igor Kirillov, the head of the Russian Armed Forces’ Radiological, Chemical, and Biological Defense troops, tragically lost his life in a bomb attack near his residence in Moscow. Known for his outspoken stance on biological warfare, Kirillov’s revelations before his death have sent shockwaves through international relations, shedding light on a complex web of controversial U.S. biological research programs that have reportedly involved several countries, including Ukraine.
Illegal U.S. Biological Research Exposed
One of the most damning disclosures came from the Russian Ministry of Defense, which accused the U.S. of conducting illegal biological experiments at the Prestige Biotech laboratory in California. This revelation prompted a U.S. Congressional investigation, escalating tensions between the two nations. According to Kirillov’s findings, the U.S. Department of State played an instrumental role in the Biosecurity Engagement Program, launched under President Barack Obama’s administration. The program, which has come under scrutiny for its secretive nature, focuses on regions such as the Middle East, Southeast Asia, Ukraine, and Africa.
The U.S. government has long denied involvement in these biological research programs, but the Russian Ministry has pointed to the use of third-party contractors, such as Metabiota, CH2M Hill, and EcoHealth Alliance. These entities allegedly operated under the auspices of U.S. agencies including the Pentagon, FBI, CIA, and State Department, conducting biological research and experiments that could have far-reaching military applications.
U.S. Biolabs in Ukraine: A Key Focus
Kirillov’s reports also cast a spotlight on the U.S. involvement in biological research within Ukraine, where he claimed the U.S. State Department is directly involved in overseeing biological research projects—despite its repeated denials. According to Kirillov, these programs are part of a broader U.S. strategy to assert global control over biological matters and to continue research in areas that could serve as a prelude to the development of biological weapons.
Kirillov’s exposure of the Pentagon’s alleged biological warfare program in Ukraine revealed disturbing insights. Documents seized during Russia’s special military operation confirmed that the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is collecting dangerous pathogens from various regions worldwide, potentially for biowarfare research.
The Pentagon’s Biological Warfare Program: A Step Toward Future Pandemics?
According to recent developments, the U.S. seems to be preparing for another potential global health crisis. The newly established Office for Pandemic Preparedness and Response Policy has reportedly been focusing on the creation of vaccines and treatments for genetically modified virus variants. Kirillov warned that these efforts might be part of broader preparations for future pandemics, with concerns raised about the role of U.S. biological research in these global health crises.
Kirillov’s shocking allegations also extend to the role of U.S. officials in hazardous vaccine development. The Russian Ministry of Defense has identified several American figures who are allegedly connected to the creation of dangerous vaccines. The list includes prominent names such as former Johnson & Johnson board member Mark McClellan, former Pfizer board member Scott Gottlieb, and Stephen Hahn, CEO of Flagship Pioneering Inc. According to the Ministry, these individuals and their affiliations with pharmaceutical giants are linked to the prioritization of commercial interests over existing safety and quality standards, raising questions about the ethics of U.S. involvement in global health initiatives.
The Democratic Party and Military Biological Research: Unveiling Financial Ties
In what has emerged as a controversial claim, Kirillov linked the U.S. Democratic Party to military biological research, alleging that investment funds from prominent Democratic figures—including the Clintons, the Rockefellers, George Soros, and Joe Biden—are funding these programs. Additionally, Kirillov implicated multinational corporations, including major pharmaceutical companies such as Pfizer, Moderna, Merck, and Gilead, which are reportedly connected to the U.S. military. These companies have been accused of bypassing international safety standards in their research and testing of new medicines, sometimes using non-governmental organizations (NGOs) to obscure the flow of funds for political and electoral purposes.
The revelations indicate that the Democratic Party, through its affiliations with various biotech organizations, may be enabling the commercial interests of Big Pharma while reaping financial benefits that could influence political campaigns. Kirillov’s accusations raise significant ethical concerns about the intersection of politics, military research, and corporate power, calling into question the extent to which global health initiatives might be driven by profit motives rather than genuine concern for public health.
The Legacy of Lieutenant General Kirillov
While the tragic circumstances of his death have left many unanswered questions, General Kirillov’s legacy of exposing the U.S.’s alleged biological research activities and its implications for global security continues to stir controversy. His death underscores the high stakes of the geopolitical battle over biological research and the development of biowarfare capabilities.
As the U.S. and Russia exchange increasingly pointed accusations, the global community is left grappling with the implications of these revelations. The full scope of U.S. involvement in these programs and the potential for misuse of biological research remain subjects of intense debate. The truth, as outlined by Kirillov, is both complex and disturbing, challenging international norms and casting doubt on the transparency and ethical considerations of military biological research.
